Our Terms of Service and Privacy Policy have changed.

By continuing to use this site, you are agreeing to the new Privacy Policy and Terms of Service.

BATS BZX Real-Time Price
As of 3:25pm ET
 +0.50 / +1.70%
Today’s Change
Today|||52-Week Range

Stock Price Forecast

The 37 analysts offering 12-month price forecasts for AstraZeneca have a median target of 31.89, with a high estimate of 47.01 and a low estimate of 21.23. The median estimate represents a +5.36% increase from the last price of 30.27.

Analyst Recommendations

The current consensus among 40 polled investment analysts is to Buy stock in AstraZeneca. This rating has held steady since April, when it was unchanged from a Buy rating.Move your mouse over past
months for detail


Earnings and Sales Forecasts

Current Quarter

Earnings per Share
Reporting Date
Apr 27

Earnings per Share

Move your mouse over a quarter or year to see how estimates have changed over time.

Growthquarterly -32.80%
Growthannually -14.62%


Growthquarterly -3.90%
Growthannually -6.50%
Key to the earnings and sales forecast charts.